M. Migden, J. Lear, N. Squittieri, L. Liu, A. Guminski, and R. Dummer, “Duration of Response and Progression-Free Survival with Sonidegib 200 Mg Once Daily Until Disease Progression or Start of New Antineoplastic Therapy in Patients with Locally Advanced Basal Cell Carcinoma: Results of the 42-Month, Randomized, Double-Blind”, J of Skin, vol. 4, no. 5, p. s68, Sep. 2020.